Clinical Trial Update: An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia [Phase 1]

View source ↗

Summary

Phase 1 exploratory study of RD140 injection in patients with relapsed/refractory multiple myeloma or plasma cell leukemia; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Leukemia

Drugs mentioned

• RD140

Snippet

Sponsor: Peking University People's Hospital | Conditions: Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia | Phase 1 | Status: NOT_YET_RECRUITING